anti-doping raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-25 and is reviewed periodically as new material appears.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
==== Section B: Thermodynamics, Equipment and Systems ==== Section B on Thermodynamics, Equipment and Systems of the IIR focuses on the technological and scientific fundamentals of classical refrigeration, excluding cryogenic temperatures. The fundamentals are represented by its Commission B1 Thermodynamics and Transfer Processes, whereas Commission B2 Refrigerating Equipment covers all kinds of refrigeration technology. Section B is a key player in most of the IIR international conferences; except for the International Conference of Refrigeration (ICR), organised every four years for all 10 IIR Commissions, where approximately 50% of all presentations are related to Section B topics. Independently, and together with other Sections, Section B hosts a multitude of conferences such as the Gustav Lorentzen Conference on Natural Working Fluids and the Ohrid Conference on Ammonia and CO2 Refrigeration Technologies; or conferences on Thermodynamic Properties and Transfer Processes of Refrigerants, on Magnetic Refrigeration at Room Temperature, on Compressors and Coolants, and on Phase Change Materials and Slurries for Refrigeration and Air Conditioning. Several Working Groups, where emerging topics in refrigeration are discussed by IIR experts to publish results in handbooks or other forms of publications, are organised within the scope of Section B.
10th Special Forces Group was responsible, among other missions, to operate a stay-behind guerrilla operation after a presumed Soviet overrunning of Western Europe, in conjunction with the program that later became controversially known as Operation Gladio. Through the Lodge-Philbin Act, it acquired a large number of Eastern European immigrants who brought many areas and language skills. Green Light Teams were Special Forces units during the height of the Cold War with the Soviet Union. These Green Light Teams, also referred to as Atomic Demolition Munitions Specialists, were trained to advance, arm, and deploy Special Atomic Demolition Munitions behind enemy lines. As well as preparing for the Warsaw Pact invasion that never came, Vietnam and other areas of South Vietnam, El Salvador, Colombia, Panama and Afghanistan are the major modern conflicts that have defined the Special Forces.
After around 12 months, the female gives live birth to two to ten pups. It takes at least two more years until she gives birth again. White sharks generally give birth during spring and summer in shallow waters surrounding islands with temperatures between 15.7 and 23.1 °C (60 and 74 °F). White sharks are born at a length of 1–1.6 m (3–5 ft). In July 2023, a possible newborn white shark was filmed for the first time, off the coast of southern California (just off Carpinteria), measuring an estimated 1.5 m (5 ft) and with a pale complexion attributed to histotrophy. A follow-up study confirmed the Carpinteria shark was a newborn but suggests that the paleness is embryonic epithelium covering the shark's skin denticles. This is known to exist in the related salmon shark and rubs off shortly after birth. Bands in the shark's vertebrae are used to determine the animal's age and growth. Early studies determined that the species grows relatively quickly; a 1985 study concluded that white sharks reach maturity nine to ten years of age at a length of 3.7–4.3 m (12–14 ft). Conversely, a 2015 study concluded that white sharks are a slow-growing and long-lived species. Males reach maturity at approximately 26 years and a length of around 3.4 m (11 ft), while females take 33 years to reach maturity at a length of around 4.6–4.9 m (15–16 ft). Their growth rate levels off after the age of 40.
In contrast, 298Fl (predicted to lie within the region of maximum shell effects) may have a much longer spontaneous fission half-life, possibly on the order of 1019 years. In the center of the island, there may be competition between alpha decay and spontaneous fission, though the exact ratio is model-dependent. The alpha decay half-lives of 1700 nuclei with 100 ≤ Z ≤ 130 have been calculated in a quantum tunneling model with both experimental and theoretical alpha decay Q-values, and are in agreement with observed half-lives for some of the heaviest isotopes. The longest-lived nuclides are also predicted to lie on the beta-stability line, for beta decay is predicted to compete with the other decay modes near the predicted center of the island, especially for isotopes of elements 111–115. Unlike other decay modes predicted for these nuclides, beta decay does not change the mass number. Instead, a neutron is converted into a proton or vice versa, producing an adjacent isobar closer to the center of stability (the isobar with the lowest mass excess). For example, significant beta decay branches may exist in nuclides such as 291Fl and 291Nh; these nuclides have only a few more neutrons than known nuclides, and might decay via a "narrow pathway" towards the center of the island of stability. The possible role of beta decay is highly uncertain, as some isotopes of these elements (such as 290Fl and 293Mc) are predicted to have shorter partial half-lives for alpha decay.
Sources: en.wikipedia.org
As long as the strategic American nuclear forces could overwhelm their Soviet counterparts, a Soviet pre-emptive strike could be averted. Moreover, the Soviet Union could not afford to build any reasonable counterforce, as the economic output of the United States was far larger than that of the Soviets, and they would be unable to achieve "nuclear parity". Soviet nuclear doctrine, however, did not match American nuclear doctrine. Soviet military planners assumed they could win a nuclear war. Therefore, they expected a large-scale nuclear exchange, followed by a "conventional war" which itself would involve heavy use of tactical nuclear weapons. American doctrine rather assumed that Soviet doctrine was similar, with the mutual in mutually assured destruction necessarily requiring that the other side see things in much the same way, rather than believing—as the Soviets did—that they could fight a large-scale, "combined nuclear and conventional" war. In accordance with their doctrine, the Soviet Union conducted large-scale military exercises to explore the possibility of defensive and offensive warfare during a nuclear war. The exercise, under the code name of "Snowball", involved the detonation of a nuclear bomb about twice as powerful as that which fell on Nagasaki and an army of approximately 45,000 soldiers on maneuvers through the hypocenter immediately after the blast. The exercise was conducted on September 14, 1954, under command of Marshal Georgy Zhukov to the north of Totskoye village in Orenburg Oblast, Russia.
=== Intellectual disability === Mutations in the CRBN gene are associated with autosomal recessive nonsyndromic intellectual disability, possibly as a result of dysregulation of calcium-activated potassium channels in the brain (see below) during development.
Nitriles are susceptible to hydrogenation over diverse metal catalysts. The reaction can afford either the primary amine (RCH2NH2) or the tertiary amine ((RCH2)3N), depending on conditions. In conventional organic reductions, nitrile is reduced by treatment with lithium aluminium hydride to the amine. Reduction to the imine followed by hydrolysis to the aldehyde takes place in the Stephen aldehyde synthesis, which uses stannous chloride in acid.
Sources: en.wikipedia.org
== Hormones == Estrogens cause the hips to widen and become rounded during puberty in females, and androgens cause the shoulders to broaden in males. Estrogens mediate epiphyseal closure in both males and females. Other hormones implicated in control of bone growth include thyroid hormone, parathyroid hormone, calcitonin, glucocorticoids such as cortisol, and vitamin D (calcitriol). According to menoPAUSE, a blog from University of Rochester, estrogen causes females to have their fat distributed in their breasts, thighs, and along their pelvic area, implying that the fat can be used as an energy source for future pregnancies. For men, androgens (such as testosterone) increases male's muscle-to-fat ratio.Woods J. "What does Estrogen Have to Do with Belly Fat?".
Jung's research and personal vision, however, made it difficult to follow his older colleague's doctrine, and they parted ways. This division was painful for Jung and resulted in the establishment of Jung's analytical psychology as a comprehensive system separate from psychoanalysis. Among the central concepts of analytical psychology is individuation—the lifelong psychological process of differentiation of the self out of each individual's conscious and unconscious elements. Jung considered it to be the main task of human development. He created some of the best-known psychological concepts, including synchronicity, archetypal phenomena, the collective unconscious, the psychological complex, and extraversion and introversion. His treatment of American businessman and politician Rowland Hazard in 1926 with his conviction that alcoholics may recover if they have a "vital spiritual (or religious) experience" played a crucial role in the chain of events that led to the formation of Alcoholics Anonymous. Jung was an artist, craftsman, builder, and prolific writer. Many of his works were not published until after his death, and some remain unpublished.
The first two roll-on/roll-off ferry berths in the Eastern Docks were opened on 30 June 1953. The first ro-ro ferry, the appropriately modified British Railways' SS Dinard, departed for Boulogne on 3 July 1953. Today, there are seven active docks for Ro-Ro vessels to utilise at Dover, one deconstructed dock and one unused dock for high-speed Ro-Ro watercraft. In 1966 well over 600,000 accompanied vehicles travelled through Dover's Eastern Docks en route to France or Belgium.
== Environmental == Micrococci have been isolated from human skin, animal and dairy products, and beer. They are found in many other places in the environment, including water, dust, and soil. M. luteus on human skin transforms compounds in sweat into compounds with an unpleasant odor. Micrococci can grow well in environments with little water or high salt concentrations, including sportswear made with synthetic fabrics. Most are mesophiles; some, like Micrococcus antarcticus (found in Antarctica) are psychrophiles. Though not a spore former, Micrococcus cells can survive for an extended period of time, both at refrigeration temperatures, and in nutrient-poor conditions such as sealed in amber.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.